Annual Operating Profit
-$129.54 M
+$12.66 M+8.90%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual operating income is -$129.54 million, with the most recent change of +$12.66 million (+8.90%) on December 31, 2023.
- During the last 3 years, KPTI annual operating profit has risen by +$42.31 million (+24.62%).
- KPTI annual operating profit is now -1156.33% below its all-time high of -$10.31 million, reached on December 31, 2011.
Performance
KPTI Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$26.28 M
+$1.84 M+6.53%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly operating income is -$26.28 million, with the most recent change of +$1.84 million (+6.53%) on September 30, 2024.
- Over the past year, KPTI quarterly operating profit has increased by +$1.84 million (+6.53%).
- KPTI quarterly operating profit is now -155.97% below its all-time high of $46.96 million, reached on December 31, 2021.
Performance
KPTI Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$125.97 M
+$4.98 M+3.80%
September 30, 2024
Summary
- As of February 8, 2025, KPTI TTM operating income is -$125.97 million, with the most recent change of +$4.98 million (+3.80%) on September 30, 2024.
- Over the past year, KPTI TTM operating profit has increased by +$4.98 million (+3.80%).
- KPTI TTM operating profit is now -3365.47% below its all-time high of -$3.63 million, reached on September 30, 2012.
Performance
KPTI TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
KPTI Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.9% | +6.5% | +3.8% |
| 3 y3 years | +24.6% | +40.0% | +30.9% |
| 5 y5 years | +28.0% | +33.3% | +33.5% |
KPTI Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -31.8% | +8.9% | -156.0% | +38.8% | -105.3% | +11.4% |
| 5 y | 5-year | -31.8% | +31.6% | -156.0% | +49.8% | -105.3% | +33.5% |
| alltime | all time | -1156.3% | +31.6% | -156.0% | +59.5% | -3365.5% | +40.9% |
Karyopharm Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$26.28 M(-6.5%) | -$125.97 M(-3.8%) |
| Jun 2024 | - | -$28.12 M(-16.7%) | -$130.95 M(-1.1%) |
| Mar 2024 | - | -$33.76 M(-10.7%) | -$132.40 M(+2.2%) |
| Dec 2023 | -$129.54 M(-8.9%) | -$37.81 M(+20.9%) | -$129.54 M(+3.1%) |
| Sep 2023 | - | -$31.26 M(+5.7%) | -$125.60 M(+0.3%) |
| Jun 2023 | - | -$29.57 M(-4.3%) | -$125.18 M(-9.6%) |
| Mar 2023 | - | -$30.90 M(-8.8%) | -$138.51 M(-2.6%) |
| Dec 2022 | -$142.20 M(+44.7%) | -$33.87 M(+9.8%) | -$142.20 M(+131.7%) |
| Sep 2022 | - | -$30.84 M(-28.1%) | -$61.37 M(-17.4%) |
| Jun 2022 | - | -$42.91 M(+24.1%) | -$74.34 M(-7.6%) |
| Mar 2022 | - | -$34.59 M(-173.6%) | -$80.48 M(-18.1%) |
| Dec 2021 | -$98.27 M(-42.8%) | $46.96 M(-207.2%) | -$98.27 M(-46.1%) |
| Sep 2021 | - | -$43.81 M(-10.7%) | -$182.30 M(-1.8%) |
| Jun 2021 | - | -$49.05 M(-6.3%) | -$185.60 M(+4.9%) |
| Mar 2021 | - | -$52.37 M(+41.3%) | -$176.87 M(+2.9%) |
| Dec 2020 | -$171.85 M(-9.2%) | -$37.07 M(-21.3%) | -$171.85 M(-3.5%) |
| Sep 2020 | - | -$47.11 M(+16.8%) | -$178.05 M(+4.5%) |
| Jun 2020 | - | -$40.32 M(-14.9%) | -$170.34 M(-0.8%) |
| Mar 2020 | - | -$47.36 M(+9.5%) | -$171.71 M(-9.3%) |
| Dec 2019 | -$189.28 M(+5.2%) | -$43.27 M(+9.8%) | -$189.28 M(-7.0%) |
| Sep 2019 | - | -$39.40 M(-5.5%) | -$203.46 M(-4.6%) |
| Jun 2019 | - | -$41.69 M(-35.8%) | -$213.22 M(+3.6%) |
| Mar 2019 | - | -$64.92 M(+13.0%) | -$205.86 M(+14.4%) |
| Dec 2018 | -$179.88 M | -$57.45 M(+16.9%) | -$179.88 M(+11.1%) |
| Sep 2018 | - | -$49.15 M(+43.2%) | -$161.88 M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$34.33 M(-11.8%) | -$143.78 M(+3.3%) |
| Mar 2018 | - | -$38.94 M(-1.3%) | -$139.20 M(+6.6%) |
| Dec 2017 | -$130.54 M(+17.9%) | -$39.45 M(+27.0%) | -$130.54 M(+10.4%) |
| Sep 2017 | - | -$31.05 M(+4.4%) | -$118.25 M(+4.7%) |
| Jun 2017 | - | -$29.75 M(-1.7%) | -$112.94 M(-0.6%) |
| Mar 2017 | - | -$30.28 M(+11.5%) | -$113.66 M(+2.6%) |
| Dec 2016 | -$110.73 M(-7.0%) | -$27.16 M(+5.5%) | -$110.73 M(-1.9%) |
| Sep 2016 | - | -$25.74 M(-15.5%) | -$112.87 M(-4.1%) |
| Jun 2016 | - | -$30.48 M(+11.4%) | -$117.74 M(-2.1%) |
| Mar 2016 | - | -$27.35 M(-6.7%) | -$120.28 M(+1.0%) |
| Dec 2015 | -$119.08 M(+57.0%) | -$29.30 M(-4.3%) | -$119.08 M(+2.9%) |
| Sep 2015 | - | -$30.61 M(-7.3%) | -$115.72 M(+10.4%) |
| Jun 2015 | - | -$33.01 M(+26.2%) | -$104.85 M(+18.8%) |
| Mar 2015 | - | -$26.15 M(+0.8%) | -$88.28 M(+16.4%) |
| Dec 2014 | -$75.85 M(+123.4%) | -$25.94 M(+31.4%) | -$75.85 M(+22.2%) |
| Sep 2014 | - | -$19.74 M(+20.0%) | -$62.05 M(+20.2%) |
| Jun 2014 | - | -$16.45 M(+20.0%) | -$51.63 M(+22.8%) |
| Mar 2014 | - | -$13.71 M(+12.9%) | -$42.05 M(+23.9%) |
| Dec 2013 | -$33.95 M(+113.7%) | -$12.15 M(+30.3%) | -$33.95 M(+30.4%) |
| Sep 2013 | - | -$9.32 M(+35.7%) | -$26.04 M(+27.9%) |
| Jun 2013 | - | -$6.87 M(+22.4%) | -$20.35 M(+50.9%) |
| Mar 2013 | - | -$5.61 M(+32.4%) | -$13.48 M(+71.3%) |
| Dec 2012 | -$15.89 M(+54.1%) | -$4.24 M(+16.6%) | -$7.87 M(+116.6%) |
| Sep 2012 | - | -$3.63 M | -$3.63 M |
| Dec 2011 | -$10.31 M | - | - |
FAQ
- What is Karyopharm Therapeutics annual operating income?
- What is the all time high annual operating profit for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual operating profit year-on-year change?
- What is Karyopharm Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly operating profit year-on-year change?
- What is Karyopharm Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics TTM operating profit year-on-year change?
What is Karyopharm Therapeutics annual operating income?
The current annual operating profit of KPTI is -$129.54 M
What is the all time high annual operating profit for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual operating income is -$10.31 M
What is Karyopharm Therapeutics annual operating profit year-on-year change?
Over the past year, KPTI annual operating income has changed by +$12.66 M (+8.90%)
What is Karyopharm Therapeutics quarterly operating income?
The current quarterly operating profit of KPTI is -$26.28 M
What is the all time high quarterly operating profit for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly operating income is $46.96 M
What is Karyopharm Therapeutics quarterly operating profit year-on-year change?
Over the past year, KPTI quarterly operating income has changed by +$1.84 M (+6.53%)
What is Karyopharm Therapeutics TTM operating income?
The current TTM operating profit of KPTI is -$125.97 M
What is the all time high TTM operating profit for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high TTM operating income is -$3.63 M
What is Karyopharm Therapeutics TTM operating profit year-on-year change?
Over the past year, KPTI TTM operating income has changed by +$4.98 M (+3.80%)